Affiliation:
1. Office of Clinical Pharmacology Office of Translational Science, Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA
Funder
U.S. Food and Drug Administration
U.S. Department of Energy
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience
Reference31 articles.
1. US Food and Drug Administration 21 CFR320.1.Bioavailability and bioequivalence requirements [online]. Accessed May 3 2017.
2. US Food and Drug Administration.Guidance for industry: bioequivalence studies with pharmacokinetic endpoints for drugs submitted under an ANDA. [online] . Accessed August 2 2017.
3. US Food and Drug Administration.Guidance for industry: bioavailability and bioequivalence studies submitted in NDAs or INDs – general considerations. [online] . Accessed August 2 2017.
4. Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitor
5. pH-Dependent Drug–Drug Interactions for Weak Base Drugs: Potential Implications for New Drug Development
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献